HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinchul Kim Selected Research

Hyperplasia

11/2020Compound K improves skin barrier function by increasing SPINK5 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinchul Kim Research Topics

Disease

7Neoplasms (Cancer)
01/2022 - 01/2018
5Stomach Neoplasms (Stomach Cancer)
01/2020 - 10/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2018
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2024 - 07/2023
2Neoplasm Metastasis (Metastasis)
05/2022 - 12/2021
2Microsatellite Instability
01/2020 - 12/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2024
1Nasopharyngeal Carcinoma
01/2023
1Carcinogenesis
01/2023
1Hepatocellular Carcinoma (Hepatoma)
05/2022
1Obesity
01/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Liver Neoplasms (Liver Cancer)
12/2021
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Hyperplasia
11/2020
1Atopic Dermatitis (Atopic Eczema)
11/2020
1Prostatic Neoplasms (Prostate Cancer)
11/2020
1Genomic Instability
01/2020
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2019
1Necrosis
09/2015
1Teratoma (Teratoid Tumor)
09/2015
1Ataxia Telangiectasia (Louis Bar Syndrome)
03/2015

Drug/Important Bio-Agent (IBA)

4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
4Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2019
2Chimeric Antigen ReceptorsIBA
05/2024 - 07/2023
2hepatitis B virus X proteinIBA
05/2022 - 12/2021
2Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2021
2B7-H1 AntigenIBA
01/2021 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 03/2015
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2020 - 03/2015
1Bispecific AntibodiesIBA
05/2024
1RNA Helicases (RNA Helicase)IBA
01/2023
1Transcription Factors (Transcription Factor)IBA
05/2022
1ASN007IBA
01/2022
1Calmodulin (Calcium-Dependent Activator Protein)IBA
12/2021
1Actin Depolymerizing Factors (Cofilins)IBA
12/2021
1CalciumIBA
12/2021
1Irinotecan (Camptosar)FDA LinkGeneric
01/2021
1afliberceptIBA
01/2021
1Leucovorin (Folinic Acid)FDA Link
01/2021
1Fluorouracil (Carac)FDA LinkGeneric
01/2021
1Docetaxel (Taxotere)FDA Link
11/2020
1Dinitrochlorobenzene (DNCB)IBA
11/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1PlatinumIBA
01/2020
1RamucirumabIBA
01/2020
1CRISPR-Associated Protein 9IBA
01/2020
1cyclopropapyrroloindoleIBA
01/2020
1taxaneIBA
01/2020
1Cell-Free Nucleic AcidsIBA
12/2019
1Tyrosine Kinase InhibitorsIBA
12/2019
11- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
10/2019
1Indicators and Reagents (Reagents)IBA
01/2018
1AntigensIBA
09/2015

Therapy/Procedure

5Therapeutics
05/2024 - 10/2019
2Immunotherapy
01/2020 - 12/2019
1Salvage Therapy
07/2023
1Castration
11/2020
1Combination Drug Therapy (Combination Chemotherapy)
01/2020
1Drug Therapy (Chemotherapy)
01/2020